--- title: "Assertio 投資者警示：Kahn Swick & Foti, LLC 正在調查擬議出售 Assertio Holdings, Inc. - ASRT 的價格和流程是否合理" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/286953224.md" description: "Kahn Swick & Foti, LLC 正在調查 Assertio Holdings, Inc. (ASRT) 擬議出售給 Garda Therapeutics 的事宜，股東將獲得每股 18.00 美元。該公司旨在評估這一價格的合理性及其形成過程，質疑是否低估了該公司。感興趣的各方可以聯繫 KSF 獲取更多信息" datetime: "2026-05-19T18:17:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286953224.md) - [en](https://longbridge.com/en/news/286953224.md) - [zh-HK](https://longbridge.com/zh-HK/news/286953224.md) --- # Assertio 投資者警示：Kahn Swick & Foti, LLC 正在調查擬議出售 Assertio Holdings, Inc. - ASRT 的價格和流程是否合理 Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRT Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Assertio Holdings, Inc. (NasdaqCM: ASRT) to Garda Therapeutics. Under the terms of the proposed transaction, shareholders of Assertio will receive $18.00 per share in cash and a contingent value right. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-asrt/ to learn more. _**Please note that the transaction is structured as a tender offer, such that time may be of the essence.**_ To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857 1100 Poydras St., Suite 960 New Orleans, LA 70163 View source version on businesswire.com: https://www.businesswire.com/news/home/20260519876676/en/ ### 相關股票 - [ASRT.US](https://longbridge.com/zh-HK/quote/ASRT.US.md) ## 相關資訊與研究 - [Assertio 終止了與 Garda 的協議，並同意以 1.664 億美元被 Zydus Worldwide DMCC 收購](https://longbridge.com/zh-HK/news/286261460.md) - [Garda 將以每股 21.80 美元的價格收購 Assertio](https://longbridge.com/zh-HK/news/285075626.md) - [Select 醫藥控股、Unifirst、Centessa Pharmaceuticals 和 Assertio 是否為其股東爭取到了公平的交易？](https://longbridge.com/zh-HK/news/286972902.md) - [Assertio宣佈與Garda Therapeutics修訂並重述合併協議](https://longbridge.com/zh-HK/news/285068087.md) - [Assertio 推遲了在待定的 Garda 收購中的要約收購](https://longbridge.com/zh-HK/news/285226139.md)